Features
A clear vision for eye care
By integrating eye health into everyday practice, pharmacists can support the early detection of many eye conditions According to Vision Initiative, pharmacists, among other primary healthcare providers, can play a …
Looking at the rural pharmacy workforce
Limitations in the size of the rural and remote pharmacy workforce disadvantages populations in these areas. Research has provided a snapshot of the situation in parts of NSW This article …
Glucagon-like peptide-1 receptor agonists for type 2 diabetes
While there are several drug classes available for treating type 2 diabetes, the glucagon-like peptide-1 (GLP-1) receptor agonists are one of the newer classes of pharmacological agents. By Carrie Stewart, …
Making a difference
Pharmacists can make a big difference to the lives of people with diabetes, says credentialled diabetes educator (CDE) Jayne Lehmann. “They can pick up a lot about a person from …
Insulin resistance insights revealed
Healthcare professionals can foster timely insulin initiation by supporting patients with realistic, accurate perceptions of diabetes and its treatment from day one. A recent study1 provides insights into some of …
Not so sweet
Guidelines are flawed and must be revised as type 2 diabetes is reversible, says the 2020 Australian of the Year. Dietary1 and clinical guidelines2 must change along with our love …
Cost of continuous glucose monitoring prohibitive for most
Findings released from one of the largest surveys of people with type 1 diabetes (T1D) reveals the cost of managing the condition is resulting in poor health outcomes, including depression. …
Fenofibrate finds fame
Diabetic retinopathy (DR) is the leading cause of preventable blindness of working-age adults in the world.1 In Australia it is one of the top five causes of irreversible blindness among …
Lockdown linked to rise in gestational diabetes
Melbourne lockdowns see gestational diabetes cases rise, while experts warn women are missing out on funded-education and support. COVID lockdowns could be behind an increase seen in the rate of …
100 years since the discovery of insulin: the roadmap to our next big breakthrough
It’s an exciting time for type 1 diabetes (T1D) research with several big breakthroughs poised to make a significant impact on the lives of people with the disease, writes Dr …
Diabetes Updates
‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …
Diabetes dynamos
Better pay and referral pathways—along with improved education and training—are desperately needed to help tackle diabetes, say award winning credentialled diabetes educators, consultant pharmacist Kirrily Chambers and registered nurse Jayne …